Evidence map›Paper›PMID 33002307›Full record

ArticleAngewandte Chemie (International ed. in English)2021

London Dispersion in Alkane Solvents.

Marcel A Strauss, Hermann A Wegner

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 31 citations in OpenAlex.

  1. A Low-Symmetry FeChemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Photoswitches beyond azobenzene: a beginner's guide.Beilstein journal of organic chemistry · 2025
    Review
  5. Context-Dependent Significance of London Dispersion.Accounts of chemical research · 2023
    Article
  6. Article
  7. Article
  8. London Dispersion in Alkane Solvents.Angewandte Chemie (International ed. in English) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Marcel A StraussInstitute of Organic Chemistry, Justus Liebig University Giessen, Heinrich-Buff-Ring 17, 35392, Giessen, Germany.
Hermann A WegnerInstitute of Organic Chemistry, Justus Liebig University Giessen, Heinrich-Buff-Ring 17, 35392, Giessen, Germany.ORCID 0000-0001-7260-6018
Justus-Liebig-Universität Gießen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The importance of London dispersion interactions in solution is an ongoing debate. Although the significance of dispersion for structure and stability is widely accepted, the degree of its attenuation in solution is still not properly understood. Quantitative evaluations are derived mostly from computations. Experimental data provide guidelines to include London dispersion in solution phase design. Herein, dispersive interactions were examined with an azobenzene probe. Alkyl substituents in meta positions of the azobenzene core were systematically varied and the effect on the half-lives for the thermally induced Z to E isomerization in several alkane solvents was determined. The results show that intramolecular dispersion is only marginally influenced. In solvents with low surface tension, reduced destabilizing solvent-solvent interactions increase the half-life up to 20 %. Specific individual interactions between alkyl chains on the azobenzene and those of the solvent lead to additional fluctuations of the half-lives. These presumably result from structural changes of the conformer ensemble.

Indexed as

azobenzeneLondon dispersionmolecular probesolvent effectsspectroscopy

Identifiers

PMID33002307
PMCPMC7821140
OpenAlexW3089939717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.